These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. CD44 antibodies and immune thrombocytopenia in the amelioration of murine inflammatory arthritis. Mott PJ; Lazarus AH PLoS One; 2013; 8(6):e65805. PubMed ID: 23785450 [TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory activity of CD44 antibodies in murine immune thrombocytopenia is mediated by Fcγ receptor inhibition. Norris PAA; Kaur G; Khan R; Zhu G; Ni H; Lazarus AH Blood; 2021 Apr; 137(15):2114-2124. PubMed ID: 33662988 [TBL] [Abstract][Full Text] [Related]
6. The neonatal Fc receptor (FcRn) is not required for IVIg or anti-CD44 monoclonal antibody-mediated amelioration of murine immune thrombocytopenia. Crow AR; Suppa SJ; Chen X; Mott PJ; Lazarus AH Blood; 2011 Dec; 118(24):6403-6. PubMed ID: 22001393 [TBL] [Abstract][Full Text] [Related]
7. Monoclonal IgG can ameliorate immune thrombocytopenia in a murine model of ITP: an alternative to IVIG. Song S; Crow AR; Freedman J; Lazarus AH Blood; 2003 May; 101(9):3708-13. PubMed ID: 12506021 [TBL] [Abstract][Full Text] [Related]
8. Relative efficacy of intravenous immunoglobulin G in ameliorating thrombocytopenia induced by antiplatelet GPIIbIIIa versus GPIbalpha antibodies. Webster ML; Sayeh E; Crow M; Chen P; Nieswandt B; Freedman J; Ni H Blood; 2006 Aug; 108(3):943-6. PubMed ID: 16861348 [TBL] [Abstract][Full Text] [Related]
9. GM-CSF and IL-4 are not involved in IVIG-mediated amelioration of ITP in mice: a role for IL-11 cannot be ruled out. Lewis BJB; Leontyev D; Neschadim A; Blacquiere M; Branch DR Clin Exp Immunol; 2018 Sep; 193(3):293-301. PubMed ID: 29704458 [TBL] [Abstract][Full Text] [Related]
10. IVIg inhibits reticuloendothelial system function and ameliorates murine passive-immune thrombocytopenia independent of anti-idiotype reactivity. Crow AR; Song S; Semple JW; Freedman J; Lazarus AH Br J Haematol; 2001 Dec; 115(3):679-86. PubMed ID: 11736954 [TBL] [Abstract][Full Text] [Related]
11. Mouse Models for Immune-Mediated Platelet Destruction or Immune Thrombocytopenia (ITP). Neschadim A; Branch DR Curr Protoc Immunol; 2016 Apr; 113():15.30.1-15.30.13. PubMed ID: 27038460 [TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies that mimic the action of anti-D in the amelioration of murine ITP act by a mechanism distinct from that of IVIg. Song S; Crow AR; Siragam V; Freedman J; Lazarus AH Blood; 2005 Feb; 105(4):1546-8. PubMed ID: 15479722 [TBL] [Abstract][Full Text] [Related]
13. Fc-independent phagocytosis: implications for IVIG and other therapies in immune-mediated thrombocytopenia. Li J; van der Wal DE; Zhu L; Vadasz B; Simpson EK; Li C; Webster ML; Zhu G; Lang S; Chen P; Zeng Q; Ni H Cardiovasc Hematol Disord Drug Targets; 2013 Mar; 13(1):50-8. PubMed ID: 23082940 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic efficacy of intravenous immunoglobulin preparations depends on the immunoglobulin G dimers: studies in experimental immune thrombocytopenia. Teeling JL; Jansen-Hendriks T; Kuijpers TW; de Haas M; van de Winkel JG; Hack CE; Bleeker WK Blood; 2001 Aug; 98(4):1095-9. PubMed ID: 11493456 [TBL] [Abstract][Full Text] [Related]
15. Effects of intravenous immunoglobulin on platelet count and antiplatelet antibody disposition in a rat model of immune thrombocytopenia. Hansen RJ; Balthasar JP Blood; 2002 Sep; 100(6):2087-93. PubMed ID: 12200371 [TBL] [Abstract][Full Text] [Related]
16. TLR2, TLR4 and the MyD88 signaling are crucial for the in vivo generation and the longevity of long-lived antibody-secreting cells. Komegae EN; Grund LZ; Lopes-Ferreira M; Lima C PLoS One; 2013; 8(8):e71185. PubMed ID: 23940714 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of antibody-coated liposomes, IVIG, and anti-RBC immunotherapy in a murine model of passive chronic immune thrombocytopenia. Deng R; Balthasar JP Blood; 2007 Mar; 109(6):2470-6. PubMed ID: 17132715 [TBL] [Abstract][Full Text] [Related]
18. Effect of intravenous immunoglobulin on inhibition of fibrinogen binding to platelets by sera from patients with immune thrombocytopenia. Kamiyama M; Yoshimura Y; Chen K; Arkel YS Am J Hematol; 1993 Oct; 44(2):77-84. PubMed ID: 8266923 [TBL] [Abstract][Full Text] [Related]
19. Dendritic cells modulate platelet activity in IVIg-mediated amelioration of ITP in mice. Huang HS; Sun DS; Lien TS; Chang HH Blood; 2010 Dec; 116(23):5002-9. PubMed ID: 20699442 [TBL] [Abstract][Full Text] [Related]
20. A role for IL-1 receptor antagonist or other cytokines in the acute therapeutic effects of IVIg? Crow AR; Song S; Semple JW; Freedman J; Lazarus AH Blood; 2007 Jan; 109(1):155-8. PubMed ID: 16954498 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]